PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
33713678-3	2021	Herein, we report the synthesis of Erg-Asp as well as some other aminoacylated ergosterols (Erg-Gly, Erg-Ala, Erg-Leu, Erg-Ile, and Erg-Val) using Boc protected amino acids.	boc	147-150	ETS transcription factor ERG	Homo sapiens	35-38
33713678-3	2021	Herein, we report the synthesis of Erg-Asp as well as some other aminoacylated ergosterols (Erg-Gly, Erg-Ala, Erg-Leu, Erg-Ile, and Erg-Val) using Boc protected amino acids.	boc	147-150	ETS transcription factor ERG	Homo sapiens	92-95
33713678-3	2021	Herein, we report the synthesis of Erg-Asp as well as some other aminoacylated ergosterols (Erg-Gly, Erg-Ala, Erg-Leu, Erg-Ile, and Erg-Val) using Boc protected amino acids.	boc	147-150	ETS transcription factor ERG	Homo sapiens	92-95
33713678-3	2021	Herein, we report the synthesis of Erg-Asp as well as some other aminoacylated ergosterols (Erg-Gly, Erg-Ala, Erg-Leu, Erg-Ile, and Erg-Val) using Boc protected amino acids.	boc	147-150	ETS transcription factor ERG	Homo sapiens	92-95
33713678-3	2021	Herein, we report the synthesis of Erg-Asp as well as some other aminoacylated ergosterols (Erg-Gly, Erg-Ala, Erg-Leu, Erg-Ile, and Erg-Val) using Boc protected amino acids.	boc	147-150	ETS transcription factor ERG	Homo sapiens	92-95
33713678-3	2021	Herein, we report the synthesis of Erg-Asp as well as some other aminoacylated ergosterols (Erg-Gly, Erg-Ala, Erg-Leu, Erg-Ile, and Erg-Val) using Boc protected amino acids.	boc	147-150	ETS transcription factor ERG	Homo sapiens	92-95
29172553-2	2017	A combination of site-selective N,N-di-Boc-activation (tert-butoxycarbonyl activation) of the amide nitrogen with practical air- and moisture-stable, well-defined, and highly reactive [Pd(NHC)(cin)Cl] (NHC = N-heterocyclic carbene; cin = cinnamyl) provides a highly effective route to biaryl ketones from primary amides in high yields.	boc	39-42	pyridoxal phosphatase	Homo sapiens	193-196
29172553-2	2017	A combination of site-selective N,N-di-Boc-activation (tert-butoxycarbonyl activation) of the amide nitrogen with practical air- and moisture-stable, well-defined, and highly reactive [Pd(NHC)(cin)Cl] (NHC = N-heterocyclic carbene; cin = cinnamyl) provides a highly effective route to biaryl ketones from primary amides in high yields.	boc	39-42	pyridoxal phosphatase	Homo sapiens	232-235
21501693-6	2011	Furthermore, pretreatment with Boc, a lipoxin A4 receptor (ALX) antagonist, significantly reversed these beneficial effects of RvD1 on LPS-induced acute lung injury in mice.	boc	31-34	formyl peptide receptor 3	Mus musculus	38-57
26843787-3	2016	In general, 1,2-amino ethanols were obtained in high yield and excellent enantiopurity by the reduction of the chiral 1,2-azido ethanols with PPh3 in water/THF, and then converted into the Boc or acetamide derivatives.	boc	189-192	caveolin 1	Homo sapiens	142-146
24237413-1	2013	A palladium(II)-catalyzed norbornene-mediated regioselective alkylation at the C-2 indole position of N-tert-butyloxycarbonyl (Boc)-protected (S)-tryptophan ethyl ester is reported.	boc	127-130	complement C2	Homo sapiens	79-82
27539268-5	2017	The insertion of a guest Aib residue into an oligo-beta-valine sequence in the octapeptide model Boc-[(beta3 (R)Val)3 -Aib-(beta3 (R)Val]4 -OMe results in well dispersed NH region in the NMR spectrum indicating folded structures in CDCl3 .	boc	97-100	eukaryotic translation elongation factor 1 beta 2 pseudogene 2	Homo sapiens	103-108
27539268-5	2017	The insertion of a guest Aib residue into an oligo-beta-valine sequence in the octapeptide model Boc-[(beta3 (R)Val)3 -Aib-(beta3 (R)Val]4 -OMe results in well dispersed NH region in the NMR spectrum indicating folded structures in CDCl3 .	boc	97-100	eukaryotic translation elongation factor 1 beta 2 pseudogene 2	Homo sapiens	124-129
25490603-2	2015	When 4,4"-biphenyldicarboxylic acid was replaced with a Boc-protected proline-functionalized linker (H(2)L) in the synthesis of DUT-32 (DUT = Dresden University of Technology), a highly porous enantiomerically pure MOF (DUT-32-NHProBoc) was obtained, as could be confirmed by enantioselective high-performance liquid chromatography (HPLC) measurements and solid-state NMR experiments.	boc	56-59	deoxyuridine triphosphatase	Homo sapiens	128-131
21501693-6	2011	Furthermore, pretreatment with Boc, a lipoxin A4 receptor (ALX) antagonist, significantly reversed these beneficial effects of RvD1 on LPS-induced acute lung injury in mice.	boc	31-34	formyl peptide receptor 3	Mus musculus	59-62
18067154-0	2008	Conformational change from antiparallel beta-sheet to alpha-helix in a series of depsipeptide, -(Leu-Leu-Lac)(n)-: syntheses, spectroscopic studies, and crystal structures of Boc-Leu-Lac-OEt and Boc-(Leu-Leu-Lac)(n)-OEt (n = 1, 2).	boc	175-178	lactase	Homo sapiens	105-108
20397160-3	2010	Moreover, the judicious selection of commercially available secondary amine catalysts allows selective access to the desired stereoisomer of the N-tert-butoxycarbonyl (Boc) or N-carbobenzyloxy (Cbz) Mannich adducts, with high control over the syn or anti relative configuration and almost perfect enantioselectivity.	boc	168-171	synemin	Homo sapiens	243-246
18434077-5	2008	We have found that the broad-spectrum caspase inhibitor Boc-Asp-CMK induced cell death at micromolar concentrations in human leukaemia cells.	boc	56-59	C-X-C motif chemokine ligand 9	Homo sapiens	64-67
18434077-11	2008	Our results further indicated that toxicity of Boc-Asp-CMK might arise from its interference with mitochondrial metabolism.	boc	47-50	C-X-C motif chemokine ligand 9	Homo sapiens	55-58
18067154-0	2008	Conformational change from antiparallel beta-sheet to alpha-helix in a series of depsipeptide, -(Leu-Leu-Lac)(n)-: syntheses, spectroscopic studies, and crystal structures of Boc-Leu-Lac-OEt and Boc-(Leu-Leu-Lac)(n)-OEt (n = 1, 2).	boc	175-178	lactase	Homo sapiens	183-186
18067154-0	2008	Conformational change from antiparallel beta-sheet to alpha-helix in a series of depsipeptide, -(Leu-Leu-Lac)(n)-: syntheses, spectroscopic studies, and crystal structures of Boc-Leu-Lac-OEt and Boc-(Leu-Leu-Lac)(n)-OEt (n = 1, 2).	boc	175-178	lactase	Homo sapiens	183-186
10657473-7	1999	Nevertheless, only one dose of BOC-CCK-4 (10 microgram/kg) completely reversed the action of morphine.	boc	31-34	cholecystokinin	Rattus norvegicus	35-38
16176265-12	2005	Recombinant prosemin preferentially cleaved benzyloxycarbonyl (Z)-His-Glu-Lys-methylcoumaryl amidide (MCA) and t-butyloxycarbonyl (Boc)-Gln-Ala-Arg-MCA.	boc	131-134	serine protease 22	Homo sapiens	12-20
8400032-0	1993	Formation of several stable complexes between the minor components of the cyclic tetrapeptide cyclo-(-Pro1-Ala2-D-Phe3-Leu4-) and some specific Boc-amino acids.	boc	144-147	lamin A/C	Homo sapiens	102-106
8956076-5	1996	Phosphoamino acid was incorporated into the N-terminal segment (1P315) at the residue corresponding to p53 serine 315 as Boc-Ser(PO3(Bzl)2)-OH during synthesis.	boc	121-124	tumor protein p53	Homo sapiens	103-106
8743562-5	1996	MTSP-1 hydrolyzed tert-butyloxycarbonyl (Boc)-Asp(OBzl)Pro-Arg-amino-4-methyl-coumaryl-7-amide (MCA) and Boc-Ile-Glu-Gly-Arg-MCA faster than Boc-Phe-Ser-Arg-MCA.	boc	41-44	suppression of tumorigenicity 14 (colon carcinoma)	Mus musculus	0-6
8201590-1	1994	A series of novel CCK tetrapeptide analogues of the general formula Boc-Trp-Lys(Tac)-N(R)-(CH2)nCON(R")Phe-NH2 (Tac = o-tolylaminocarbonyl), where R,R" = H or Me and n = 1-5, have been synthesized and tested.	boc	68-71	cholecystokinin	Rattus norvegicus	18-21
8946799-2	1996	The central Gly-Gly segment of the helical octapeptide Boc-Leu-Aib-Val-Gly-Gly-Leu-Aib-Val-OMe(1) has been replaced by delta-amino-valeric acid (delta-Ava) residue in the newly designed peptide Boc-Leu-Aib-Val-delta-Ava-Leu-Aib-Val-OMe(2).	boc	55-58	ANIB1	Homo sapiens	63-66
8946799-2	1996	The central Gly-Gly segment of the helical octapeptide Boc-Leu-Aib-Val-Gly-Gly-Leu-Aib-Val-OMe(1) has been replaced by delta-amino-valeric acid (delta-Ava) residue in the newly designed peptide Boc-Leu-Aib-Val-delta-Ava-Leu-Aib-Val-OMe(2).	boc	55-58	ANIB1	Homo sapiens	83-86
8946799-2	1996	The central Gly-Gly segment of the helical octapeptide Boc-Leu-Aib-Val-Gly-Gly-Leu-Aib-Val-OMe(1) has been replaced by delta-amino-valeric acid (delta-Ava) residue in the newly designed peptide Boc-Leu-Aib-Val-delta-Ava-Leu-Aib-Val-OMe(2).	boc	55-58	ANIB1	Homo sapiens	83-86
8946799-2	1996	The central Gly-Gly segment of the helical octapeptide Boc-Leu-Aib-Val-Gly-Gly-Leu-Aib-Val-OMe(1) has been replaced by delta-amino-valeric acid (delta-Ava) residue in the newly designed peptide Boc-Leu-Aib-Val-delta-Ava-Leu-Aib-Val-OMe(2).	boc	55-58	ANIB1	Homo sapiens	83-86
8400032-0	1993	Formation of several stable complexes between the minor components of the cyclic tetrapeptide cyclo-(-Pro1-Ala2-D-Phe3-Leu4-) and some specific Boc-amino acids.	boc	144-147	dihydrolipoamide dehydrogenase	Homo sapiens	114-118
34573967-6	2021	The serum IL-8 and TNF-alpha concentration measured in the OC Group was significantly higher than in the BOC Group (p < 0.05).	boc	105-108	C-X-C motif chemokine ligand 8	Homo sapiens	10-14
8408427-2	1993	The target sequence was assembled using tert.-butoxycarbonyl (Boc) chemistry in stepwise fashion from the C-terminal on an Boc-Asn-OCH2-Pam-copoly(styrene-divinylbenzene) resin [Pam = 4-(carboxamidomethyl)benzyl ester].	boc	62-65	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	136-139
8408427-2	1993	The target sequence was assembled using tert.-butoxycarbonyl (Boc) chemistry in stepwise fashion from the C-terminal on an Boc-Asn-OCH2-Pam-copoly(styrene-divinylbenzene) resin [Pam = 4-(carboxamidomethyl)benzyl ester].	boc	62-65	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	178-181
2236010-1	1990	The crystal structure of the decapeptide Boc-Aib-Glu(OBzl)-Leu-Aib-Ala-Leu-Aib-Ala-Lys(Z)-Aib-OMe (where Aib is alpha-aminoisobutyryl, Boc is t-butoxycarbonyl, OBzl is benzyl ester, and Z is benzyloxycarbonyl) illustrates a parallel zipper arrangement of interacting helical peptide columns.	boc	41-44	ANIB1	Homo sapiens	45-48
2236010-1	1990	The crystal structure of the decapeptide Boc-Aib-Glu(OBzl)-Leu-Aib-Ala-Leu-Aib-Ala-Lys(Z)-Aib-OMe (where Aib is alpha-aminoisobutyryl, Boc is t-butoxycarbonyl, OBzl is benzyl ester, and Z is benzyloxycarbonyl) illustrates a parallel zipper arrangement of interacting helical peptide columns.	boc	41-44	ANIB1	Homo sapiens	63-66
2236010-1	1990	The crystal structure of the decapeptide Boc-Aib-Glu(OBzl)-Leu-Aib-Ala-Leu-Aib-Ala-Lys(Z)-Aib-OMe (where Aib is alpha-aminoisobutyryl, Boc is t-butoxycarbonyl, OBzl is benzyl ester, and Z is benzyloxycarbonyl) illustrates a parallel zipper arrangement of interacting helical peptide columns.	boc	41-44	ANIB1	Homo sapiens	63-66
2236010-1	1990	The crystal structure of the decapeptide Boc-Aib-Glu(OBzl)-Leu-Aib-Ala-Leu-Aib-Ala-Lys(Z)-Aib-OMe (where Aib is alpha-aminoisobutyryl, Boc is t-butoxycarbonyl, OBzl is benzyl ester, and Z is benzyloxycarbonyl) illustrates a parallel zipper arrangement of interacting helical peptide columns.	boc	41-44	ANIB1	Homo sapiens	63-66
2236010-1	1990	The crystal structure of the decapeptide Boc-Aib-Glu(OBzl)-Leu-Aib-Ala-Leu-Aib-Ala-Lys(Z)-Aib-OMe (where Aib is alpha-aminoisobutyryl, Boc is t-butoxycarbonyl, OBzl is benzyl ester, and Z is benzyloxycarbonyl) illustrates a parallel zipper arrangement of interacting helical peptide columns.	boc	41-44	ANIB1	Homo sapiens	63-66
1483834-0	1992	Conformational regions of Boc-Ala-Aib-Ala-OMe.	boc	26-29	ANIB1	Homo sapiens	34-37
34396378-10	2021	Also, histological and computed tomographic findings evidenced enhanced bone regeneration in the group treated with the BOC/ALN/BMP hydrogel construct in a rabbit tibial defect model.	boc	120-123	bone morphogenetic protein 2	Gallus gallus	128-131
34573967-6	2021	The serum IL-8 and TNF-alpha concentration measured in the OC Group was significantly higher than in the BOC Group (p < 0.05).	boc	105-108	tumor necrosis factor	Homo sapiens	19-28
2915976-1	1989	Two molecules of Boc-Aib-Val-Aib-Aib-Val-Val-Val-Aib-Val-Aib-OMe (where Boc is t-butoxycarbonyl and Aib is alpha-aminoisobutyryl) cocrystallize in a triclinic cell with different helical conformations.	boc	17-20	ANIB1	Homo sapiens	21-24
2489100-4	1989	Temperature dependence of NH proton chemical shift and NOE experiments showed that Boc-Asn-Aib-Thr-Aib-OMe has a tendency to form a beta-turn structure with a hydrogen bond involving Thr and Aib4 NH groups.	boc	83-86	ANIB1	Homo sapiens	91-94
2489100-4	1989	Temperature dependence of NH proton chemical shift and NOE experiments showed that Boc-Asn-Aib-Thr-Aib-OMe has a tendency to form a beta-turn structure with a hydrogen bond involving Thr and Aib4 NH groups.	boc	83-86	ANIB1	Homo sapiens	99-102
2489100-4	1989	Temperature dependence of NH proton chemical shift and NOE experiments showed that Boc-Asn-Aib-Thr-Aib-OMe has a tendency to form a beta-turn structure with a hydrogen bond involving Thr and Aib4 NH groups.	boc	83-86	amyloid beta precursor protein	Homo sapiens	130-136
2554881-10	1989	Km values for the hydrolysis of CCK-8, [Leu15]gastrin-(11-17)-peptide and Boc-[Leu15]gastrin-(14-17)-peptide at an NaCl concentration of 300 mM were respectively 115, 420 and 3280 microM, and the catalytic constants were about 33, 115 and 885 min-1.	boc	74-77	gastrin	Oryctolagus cuniculus	85-92
2915976-1	1989	Two molecules of Boc-Aib-Val-Aib-Aib-Val-Val-Val-Aib-Val-Aib-OMe (where Boc is t-butoxycarbonyl and Aib is alpha-aminoisobutyryl) cocrystallize in a triclinic cell with different helical conformations.	boc	17-20	ANIB1	Homo sapiens	29-32
2915976-1	1989	Two molecules of Boc-Aib-Val-Aib-Aib-Val-Val-Val-Aib-Val-Aib-OMe (where Boc is t-butoxycarbonyl and Aib is alpha-aminoisobutyryl) cocrystallize in a triclinic cell with different helical conformations.	boc	17-20	ANIB1	Homo sapiens	29-32
2915976-1	1989	Two molecules of Boc-Aib-Val-Aib-Aib-Val-Val-Val-Aib-Val-Aib-OMe (where Boc is t-butoxycarbonyl and Aib is alpha-aminoisobutyryl) cocrystallize in a triclinic cell with different helical conformations.	boc	17-20	ANIB1	Homo sapiens	29-32
2915976-1	1989	Two molecules of Boc-Aib-Val-Aib-Aib-Val-Val-Val-Aib-Val-Aib-OMe (where Boc is t-butoxycarbonyl and Aib is alpha-aminoisobutyryl) cocrystallize in a triclinic cell with different helical conformations.	boc	17-20	ANIB1	Homo sapiens	29-32
2915976-1	1989	Two molecules of Boc-Aib-Val-Aib-Aib-Val-Val-Val-Aib-Val-Aib-OMe (where Boc is t-butoxycarbonyl and Aib is alpha-aminoisobutyryl) cocrystallize in a triclinic cell with different helical conformations.	boc	17-20	ANIB1	Homo sapiens	29-32
2927258-8	1989	Butoxycarbonyl (BOC)-CCK31-33-amide increased basal colonic motility, but did not alter CCK-OP-induced responses at doses of 0.1 and 0.2 mg/Kg.	boc	16-19	cholecystokinin	Canis lupus familiaris	21-24
3866608-2	1985	Among the latter, the shortest substrate was tert-butoxycarbonylaspartyltyrosine (Boc-Asp-Tyr), but the reaction was optimized by increasing the length of the peptide sequence on the C-terminal side up to tert-butoxycarbonylcholecystokinin octapeptide (Boc-CCK-8) as well as by the presence of acidic amino acid residues at the N-terminal side.	boc	82-85	cholecystokinin	Rattus norvegicus	257-260
3098281-1	1986	Two model peptides Boc-Asp-Pro-Aib-X-NHMe [X = His (1) and X = Lys (2)] were synthesized to simulate intramolecular electrostatic interactions between ionizable side chains.	boc	19-22	ANIB1	Homo sapiens	31-34
3710691-2	1986	The conformation of the peptide Boc-L-Met-Aib-L-Phe-OMe has been studied in the solid state and solution by X-ray diffraction and 1H n.m.r., respectively.	boc	32-35	ANIB1	Homo sapiens	42-45